Bristol-Myers Squibb Company
Pembelian
Diupdate

BMY Swing Trade

403
Bristol-Myers Squibb Co (BMY)

BMY has been on a downtrend since December 2022 but since its recent Dividend payout followed by good earnings, it seems like a reversal of trend is in the making.

Following a month-long consolidation period, a bullish candlestick formation at today's close could indicate a favourable entry point. I anticipate a short-term price movement towards $53.
Trading ditutup: target tercapai
TP reached!

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.